290 related articles for article (PubMed ID: 23883553)
1. Current knowledge and treatment strategies for grade II gliomas.
Narita Y
Neurol Med Chir (Tokyo); 2013; 53(7):429-37. PubMed ID: 23883553
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant temozolomide-based chemoradiotherapy versus radiotherapy alone in patients with WHO III astrocytoma: The Mainz experience.
Mayer A; Schwanbeck C; Sommer C; Stockinger M; Giese A; Renovanz M; Vaupel P; Schmidberger H
Strahlenther Onkol; 2015 Aug; 191(8):665-71. PubMed ID: 26025143
[TBL] [Abstract][Full Text] [Related]
3. Impact of 1p/19q codeletion and histology on outcomes of anaplastic gliomas treated with radiation therapy and temozolomide.
Speirs CK; Simpson JR; Robinson CG; DeWees TA; Tran DD; Linette G; Chicoine MR; Dacey RG; Rich KM; Dowling JL; Leuthardt EC; Zipfel GJ; Kim AH; Huang J
Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):268-76. PubMed ID: 25636755
[TBL] [Abstract][Full Text] [Related]
4. Radiotherapy versus radiotherapy combined with temozolomide in high-risk low-grade gliomas after surgery: study protocol for a randomized controlled clinical trial.
Wang J; Wang Y; He Y; Guan H; He L; Mu X; Peng X
Trials; 2019 Nov; 20(1):641. PubMed ID: 31752981
[TBL] [Abstract][Full Text] [Related]
5. Updated therapeutic strategy for adult low-grade glioma stratified by resection and tumor subtype.
Nitta M; Muragaki Y; Maruyama T; Iseki H; Ikuta S; Konishi Y; Saito T; Tamura M; Chernov M; Watanabe A; Okamoto S; Maebayashi K; Mitsuhashi N; Okada Y
Neurol Med Chir (Tokyo); 2013; 53(7):447-54. PubMed ID: 23883555
[TBL] [Abstract][Full Text] [Related]
6. Upfront Therapy of Aggressive/High-Risk Low-Grade Glioma: Single-Institution Outcome Analysis of Temozolomide-Based Radio-Chemotherapy and Adjuvant Chemotherapy.
Anand S; Chatterjee A; Gupta T; Panda P; Moiyadi A; Epari S; Patil V; Krishnatry R; Goda JS; Jalali R
World Neurosurg; 2021 Oct; 154():e176-e184. PubMed ID: 34245877
[TBL] [Abstract][Full Text] [Related]
7. Impact of adjuvant treatments on survival in Korean patients with WHO grade II gliomas: KNOG 15-02 and KROG 16-04 intergroup study.
Koo T; Lim DH; Seol HJ; Dho YS; Kim IH; Chang JH; Lee J; Jung TY; Gwak HS; Cho KH; Hong CK; Lee IJ; Kim E; Kim JH; Hong YK; Jang HS; Kim CY; Kim IA; Kim SH; Kim YI; Kim EY; Kim WC; Hong S
J Neurooncol; 2018 Nov; 140(2):445-455. PubMed ID: 30097825
[TBL] [Abstract][Full Text] [Related]
8. Proposed therapeutic strategy for adult low-grade glioma based on aggressive tumor resection.
Nitta M; Muragaki Y; Maruyama T; Ikuta S; Komori T; Maebayashi K; Iseki H; Tamura M; Saito T; Okamoto S; Chernov M; Hayashi M; Okada Y
Neurosurg Focus; 2015 Jan; 38(1):E7. PubMed ID: 25599276
[TBL] [Abstract][Full Text] [Related]
9. Low-grade gliomas.
Stieber VW
Curr Treat Options Oncol; 2001 Dec; 2(6):495-506. PubMed ID: 12057095
[TBL] [Abstract][Full Text] [Related]
10. Adult low-grade glioma: 19-year experience at a single institution.
Youland RS; Brown PD; Giannini C; Parney IF; Uhm JH; Laack NN
Am J Clin Oncol; 2013 Dec; 36(6):612-9. PubMed ID: 22892428
[TBL] [Abstract][Full Text] [Related]
11. [Treatment modalities for malignant gliomas with reference to their pathophysiology].
Kobayashi S; Takakura K
Gan To Kagaku Ryoho; 1986 Jan; 13(1):11-7. PubMed ID: 3942392
[TBL] [Abstract][Full Text] [Related]
12. Postsurgical Approaches in Low-Grade Oligodendroglioma: Is Chemotherapy Alone Still an Option?
Franceschi E; Tosoni A; De Biase D; Lamberti G; Danieli D; Pizzolitto S; Zunarelli E; Visani M; Di Oto E; Mura A; Minichillo S; Scafati C; Asioli S; Paccapelo A; Bartolini S; Brandes AA
Oncologist; 2019 May; 24(5):664-670. PubMed ID: 30777895
[TBL] [Abstract][Full Text] [Related]
13. Treatment Outcomes in 1p19q Co-deleted/Partially Deleted Gliomas.
McNamara MG; Jiang H; Lim-Fat MJ; Sahebjam S; Kiehl TR; Karamchandani J; Coire C; Chung C; Millar BA; Laperriere N; Mason WP
Can J Neurol Sci; 2017 May; 44(3):288-294. PubMed ID: 28488951
[TBL] [Abstract][Full Text] [Related]
14. Diffuse Infiltrating Oligodendroglioma and Astrocytoma.
van den Bent MJ; Smits M; Kros JM; Chang SM
J Clin Oncol; 2017 Jul; 35(21):2394-2401. PubMed ID: 28640702
[TBL] [Abstract][Full Text] [Related]
15. Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma.
Buckner JC; Shaw EG; Pugh SL; Chakravarti A; Gilbert MR; Barger GR; Coons S; Ricci P; Bullard D; Brown PD; Stelzer K; Brachman D; Suh JH; Schultz CJ; Bahary JP; Fisher BJ; Kim H; Murtha AD; Bell EH; Won M; Mehta MP; Curran WJ
N Engl J Med; 2016 Apr; 374(14):1344-55. PubMed ID: 27050206
[TBL] [Abstract][Full Text] [Related]
16. Combined treatment modality for anaplastic oligodendroglioma: a phase II study.
Jeremic B; Shibamoto Y; Gruijicic D; Milicic B; Stojanovic M; Nikolic N; Dagovic A; Aleksandrovic J
J Neurooncol; 1999 Jun; 43(2):179-85. PubMed ID: 10533731
[TBL] [Abstract][Full Text] [Related]
17. Malignant astrocytic gliomas in children.
Marchese MJ; Chang CH
Cancer; 1990 Jun; 65(12):2771-8. PubMed ID: 2160318
[TBL] [Abstract][Full Text] [Related]
18. Radiochemotherapy of malignant glioma in adults. Clinical experiences.
Kortmann RD; Jeremic B; Weller M; Plasswilm L; Bamberg M
Strahlenther Onkol; 2003 Apr; 179(4):219-32. PubMed ID: 12707711
[TBL] [Abstract][Full Text] [Related]
19. New clinical, pathological and molecular prognostic models and calculators in patients with locally diagnosed anaplastic oligodendroglioma or oligoastrocytoma. A prognostic factor analysis of European Organisation for Research and Treatment of Cancer Brain Tumour Group Study 26951.
Gorlia T; Delattre JY; Brandes AA; Kros JM; Taphoorn MJ; Kouwenhoven MC; Bernsen HJ; Frénay M; Tijssen CC; Lacombe D; van den Bent MJ
Eur J Cancer; 2013 Nov; 49(16):3477-85. PubMed ID: 23896377
[TBL] [Abstract][Full Text] [Related]
20. Adults with newly diagnosed high-grade gliomas.
Croteau D; Mikkelsen T
Curr Treat Options Oncol; 2001 Dec; 2(6):507-15. PubMed ID: 12057096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]